Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

Antonio Palumbo, Hervé Avet‐Loiseau, Stefania Oliva, +28

Journal of Clinical Oncology

The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study.

Livio Pagano, Morena Caira, Anna Candoni, +19

PubMed

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

Meletios Α. Dimopoulos, Philippe Moreau, Antonio Palumbo, +28

The Lancet Oncology

Hematological MalignancyOncologyDexamethasone Versus BortezomibHematologyMyeloid Neoplasia +6

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

Michèle Cavo, Paola Tacchetti, Francesca Patriarca, +17

The Lancet

Hematological MalignancyTransplantationMarrow TransplantationOncologyRandomised Phase 3 +8

Autologous Transplantation and Maintenance Therapy in Multiple Myeloma

Antonio Palumbo, Federica Cavallo, Francesca Gay, +24

New England Journal of Medicine

Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report

Antonio Palumbo, Sara Bringhen, María‐Victoria Mateos, +24

Blood

Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: A Randomized Controlled Trial

Antonio Palumbo, Davide Rossi, Maide Cavalli, +20

Journal of Clinical Oncology

Fungal Infections in Recipients of Hematopoietic Stem Cell Transplants: Results of the SEIFEM B-2004 Study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne

Livio Pagano, Morena Caira, Annamaria Nosari, +18

Clinical Infectious Diseases

Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial

Antonio Palumbo, Michèle Cavo, Elena Zamagni, +28

Journal of Clinical Oncology

Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial

Francesca Gay, Stefania Oliva, Maria Teresa Petrucci, +23

The Lancet Oncology

Hematological MalignancyTransplantationMarrow TransplantationMedicineImmunology +10